Affymetrix to Shutter, Consolidate Massachusetts Manufacturing and Development Facility | GenomeWeb
NEW YORK (GenomeWeb News) – Affymetrix will shutter its instrument manufacturing and development facility in Bedford, Mass., this winter as part of a broader plan to cut costs, according to a filing with Securities and Exchange Commission yesterday.
 
The move, which Affy “committed to” on Sept. 7, will consolidate the facility's instrument manufacturing operations with the company's probe array-manufacturing space in West Sacramento, Calif.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.